Marianne Norskov - Acarix AS Chief Officer

All Insiders . Sweden . 
Stock . Acarix AS . Stakeholders . Insider . Marianne Norskov
ACARIX Stock  SEK 0.31  0.01  3.33%   

Insider

Marianne Norskov is Chief Officer of Acarix AS
Age 45
Phone46 1 04 71 58 02
Webhttps://www.acarix.com

Acarix AS Management Efficiency

The company has return on total asset (ROA) of (0.7996) % which means that it has lost $0.7996 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.458) %, meaning that it generated substantial loss on money invested by shareholders. Acarix AS's management efficiency ratios could be used to measure how well Acarix AS manages its routine affairs as well as how well it operates its assets and liabilities.
Acarix AS has accumulated 239 K in total debt with debt to equity ratio (D/E) of 2.3, implying the company greatly relies on financing operations through barrowing. Acarix AS has a current ratio of 7.23, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Acarix AS until it has trouble settling it off, either with new capital or with free cash flow. So, Acarix AS's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acarix AS sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acarix to invest in growth at high rates of return. When we think about Acarix AS's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Tomas AnderssonBiovica International AB
63
Dominique TersagoCantargia AB
61
Karin NielsenSaniona AB
N/A
Max SogaardExpreS2ion Biotech Holding
N/A
Anita BComSaniona AB
55
Rami LevinSaniona AB
54
Ignacio GarciaRibasCantargia AB
N/A
MBA MScSaniona AB
63
Mattias BergqvistBiovica International AB
53
Henrik DVMBiovica International AB
57
Otti GrefBiovica International AB
55
Cecilia DrivingBiovica International AB
52
Thoas MDCantargia AB
61
Nina ValkamaCantargia AB
N/A
Kjell SjstrmCantargia AB
N/A
Adnan DeronicCantargia AB
N/A
Bent MScExpreS2ion Biotech Holding
N/A
Lars PetersenExpreS2ion Biotech Holding
N/A
Anders RylanderBiovica International AB
53
Jorgen DrejerSaniona AB
68
Warren CresswellBiovica International AB
55
Acarix AB , a medical technology company, develops and commercializes diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Acarix AB was founded in 2004 and is based in Malm, Sweden. Acarix AB operates under Medical Devices classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11 people. Acarix AS (ACARIX) is traded on Stockholm Exchange in Sweden and employs 8 people.

Management Performance

Return On Equity-1.46
Return On Asset-0.8

Acarix AS Leadership Team

Elected by the shareholders, the Acarix AS's board of directors comprises two types of representatives: Acarix AS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acarix. The board's role is to monitor Acarix AS's management team and ensure that shareholders' interests are well served. Acarix AS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acarix AS's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christian Lindholm, Chief Officer
Marianne Norskov, Chief Officer
Helen Round, Pres CEO
Thomas Lundstrm, Chief Officer
Tobias Fritz, Chief Officer
Anders Krabbe, Chief Officer

Acarix Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Acarix AS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-1.46
Return On Asset-0.8
Operating Margin(13.75) %
Current Valuation51.77 M
Shares Outstanding373.33 M
Shares Owned By Insiders10.28 %
Shares Owned By Institutions2.84 %
Price To Book1.63 X
Price To Sales15.38 X
Revenue3.76 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Acarix Stock

Acarix AS financial ratios help investors to determine whether Acarix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Acarix with respect to the benefits of owning Acarix AS security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY